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ABSTRACT
Human amniotic fluid stem cells (hAFSCs) may be useful for regenerative medicine because of their
potential to differentiate into all three germ layers and tomodulate immune response with different
types of secretionmolecules. This last issue has not been completely elucidated. The aimof this study
was to investigate the secretome profile of the hAFSC, focusing on the role of hepatocyte growth fac-
tor (HGF) in immunoregulation through short and long cocultureswithhumanperipheral bloodmono-
nuclear cells. We found that HGF produced by hAFSCs exerts a cytoprotective role, inducing an
increase in caspase-dependent apoptosis in human immune cells. This study provides evidence sup-
porting the hypothesis that amniotic fluid is an ideal source of stem cells for expansion and banking
properties for therapeutic use. hAFSCs not only are less immunogenic but also can secrete immuno-
regulatory factors that may be useful in autoimmune diseases or allogenic implants. STEM CELLS
TRANSLATIONAL MEDICINE 2015;4:539–547
SIGNIFICANCE
New information about the secretome pattern is reported in this paper. Human amniotic fluid stem
cells (hAFSCs) possess immunomodulatory properties involving hepatocyte growth factor produc-
tion. hAFSCs could be used in immunotherapies and might be able to avoid allogenic rejection.
INTRODUCTION
Mesenchymal stem cells (MSCs) show immuno-
modulatory activity and secrete a wide spectrum
of cytokines and chemokines that suppress
inflammatory responses, that block mixed lym-
phocyte reactions and other immune reactions,
and that have proven therapeutic effects against
conditions such as graft-versus-host disease [1].
Immunoregulation by bone marrow MSCs (BM-
MSCs) is thought to result from both direct inter-
actions between the stromal and immune cells
[2–4] and the actions of anti-inflammatory solu-
ble factors released by the stromal cells [5, 6].
However, the relatively limited proliferation of
BM-MSCs under standard conditions, suitable
for manufacture of a clinical product, presents
a potential drawback for theirmedical application
[7]. Tissue engineering and cell therapywill be en-
hanced by improved cell sources.
Human amniotic fluid stem cells (hAFSCs) are
broadly multipotent, can be expanded exten-
sively in culture, are not tumorigenic, and can
be readily cryopreserved for cell banking. hAFSCs
resembleMSCs inmany respects including surface
marker expression and differentiation potential.
The population of multipotent stem cells
from amniotic fluid is obtained by immunoselec-
tion for c-Kit (CD117) [8], the cell surface receptor
for stem cell factor, and is characterized by
a high capacity for self-renewal and the ability
to differentiate toward lineages representative
of all three germ layers including glial cells, neu-
rons, hepatocytes, osteocytes, chondrocytes,
and adipocytes [8–11].
Both hAFSCs and BM-MSCs express surface
markers CD29, CD44, CD73, CD90, and CD105,
but hAFSCs also express the more primitive stem
cell markers SSEA4 [8], Oct4, Nanog, and Sox2
[12]. The two cell types also have a similar immune
antigen surface profiles with positive major histo-
compatibility complex (MHC) class I expressionbut
little to noMHC class II expression [13].Moreover,
amniotic fluid cells may have an immunoprivi-
ledged status because fetal cells must possess
mechanisms to avoid destruction by the maternal
immune system during development [14].
In vivo experimentswith hAFSCs have not had
successful results. hAFSCs xenotransplanted in
a ratmodel ofmyocardial infarction, with orwith-
out cyclosporine treatment, or in intact heart
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animalswere acutely rejected [15]. These authors have continued
to investigate the immune regulatory potential of hAFSCs [16] be-
cause the prior experiment was cross-species. It may be possible
to use amniotic fluid cells in an allogenic fashion, in addition to
a potential autologous use for congenital defects. The authors
found that exposure to an inflammatory milieu leads to ac-
tivation of the tryptophan-catabolizing enzyme indoleamine
2,3-dioxygenase (IDO), which becomes the central immunosup-
pressive enzyme affecting T-cell proliferation in several stem cells
types, including hAFSCs [17], even if some other molecules may
be involved [16, 18]. In fact, c-Kit-positive cells fromamniotic fluid
were described as exerting an immunomodulatory effect through
cytokines separate from IDO secretion [18]. Moorefield et al.
demonstrated that AFSCs secrete multiple factors in common
with MSCs that are known to be involved in immune regulation,
including growth-related oncogene and monocyte chemotactic
protein (MCP) family members and interleukin-6 (IL-6). AFSCs,
activated by exposure to peripheral blood mononuclear cells
(PBMCs), released several additional cytokines compared with
BM-MSCs [1].
Among secreted cytoprotective factors, hepatocyte growth
factor (HGF) and matrix metalloproteinases 2 and 9 were identi-
fied [1, 19, 20]. HGF is a cytokine with angiogenic potential and is
likely released in theblood, suggesting its endocrine role in target-
ing the injury site. Endogenous HGF is required for self-repair of
injured liver, kidneys, lungs, and other organs. In addition, HGF
exerts protective effects on epithelial and nonepithelial organs
(including heart and brain) through antiapoptotic and anti-
inflammatory signals. In linewith other soluble factors associated
with regenerative processes, HGF-1 possesses immune-
modulatory activity [21]. Treatment of dendritic cells with HGF-1
reduces the ability to induce generation of inflammatory Th1
cells [22]. Furthermore, studies have shown that in vivo admin-
istration of HGF-1 protects against autoimmune diseases, such
as experimental autoimmune encephalomyelitis and collagen-
induced arthritis, through stimulation of regulatory T cells pro-
ducing immune-suppressive cytokines [23, 24].MSC production
of HGF-1 has been shown to be critical in several in vivo thera-
peutic activities of MSCs in models of autoimmunity [21].
We investigated the role of HGF, a soluble factor with both
regenerative and immune modulatory activities that is secreted
byhAFSCs, in the regulation of immune response. This studydem-
onstrated that hAFSCsmay counteract allogenic rejection by pro-
moting cell survival, also through HGF secretion.
MATERIALS AND METHODS
Adult Human Tissue Isolation and Cell Culture
Amniocentesis samples taken during the second trimester of
pregnancy (6back-up flasks obtained fromdifferent donors)were
provided by the Laboratorio di Genetica, Ospedale Santa Maria
Nuova (Reggio Emilia, Italy). All samples were collected with
the informed consent of the donors (aged$35 years) according
to Italian law and ethics committee guidelines.
The hAFSCswere isolated, as described previously [8]. Human
amniocentesis cultures were harvested by trypsinization and
subjected to c-Kit immunoselection by MACS technology
(Miltenyi Biotec, Bergisch Gladbach, Germany, http://www.
miltenyibiotec.com). The hAFSCs were subcultured routinely
at 1:3 dilution and were not allowed to expand beyond 70% of
confluence. The hAFSCs were grown in culture medium (Min-
imum Essential Medium, a modification, supplemented with
20% fetal bovine serum [FBS], 2 mM L-glutamine, 100 U/ml
penicillin, and 100 mg/ml streptomycin; EuroClone, Milan,
Italy, http://www.euroclonegroup.it) [25]. Osteogenic differ-
entiation was obtained after 2 weeks of culture in a classic os-
teogenic medium, as described by Maraldi et al. [25, 26].
Neurogenic differentiation occurred after 3weeks inmedium
containing retinoic acid [9].
Assessment of Cytokines/Chemokines Levels by
Antibody Microarrays
The levels of cytokines IL-1a, IL-1b, IL-4, IL-6, IL-10, IL-13, inter-
feron-b (IFN-b), tumor necrosis factor-a (TNF-a) and chemokines
IL-8 and MCP-1 were assessed in conditioned media obtained af-
ter 5 days of culture of hAFSCs (preactivated or not) with the
Quantibody Human Inflammation Array 1 (Ray Biotech, Norcross,
GA, http://www.raybiotech.com). In detail, the kit provides
microarray slides, each spotted with 16 copies of a cytokine/
chemokine antibody array. The slide comeswith a 16-well remov-
able gasket that allows for the process of 16 samples in 1 slide.
Every array consists of 6 3 8 matrices in quadruplicate for each
antibody and 2 positive controls.
Prior to processing, the sampleswere diluted 1:10 in the appro-
priate diluent buffer provided in the kit, and the assays were con-
ducted according to a sandwich enzyme-linked immunosorbent
assay (ELISA)protocol, according to themanufacturer’s instructions.
The fluorescent signal was read with a ScanArray GX scanner
(PerkinElmer, Waltham, MA, http://www.perkinelmer.com) and
quantified with the ScanArray Express software (PerkinElmer).
The quantification of each cytokine or chemokine was
achieved by interpolating the fluorescent signals to the standard
curve, generated by processing some arrays with specific stan-
dards containing predetermined cytokines concentrations (pico-
grams per milliliter) [27].
Immunofluorescence and Confocal Microscopy
For immunofluorescence analysis, sampleswere processed as de-
scribed previously [28]. Confocal imaging was performed by
a Nikon A1 confocal laser scanning microscope (Nikon, Tokyo,
Japan, http://www.nikon.com), as described previously [29]. Pri-
mary antibody against HGF (rabbit anti-HGF H-170, catalog num-
ber sc-13087) was purchased from Santa Cruz Biotechnology
(Dallas TX, http://www.scbt.com). The primary antibody was di-
luted 1:50 and incubated for 1 hour at room temperature.
The confocal serial sections were processedwith ImageJ soft-
ware (NIH, Bethesda, MD, http://imagej.nih.gov/ij/) to obtain
three-dimensional projections, as described previously [30].
The image rendering was performedwith Adobe Photoshop soft-
ware (Adobe Systems, San Jose, CA, http://www.adobe.com).
Mononuclear Cell Separation
Human PBMCs were separated from peripheral blood of healthy
donors by gradient centrifugation (Ficoll-Hypaque, Lymphoprep;
Axis-Shield, Dundee, U.K., http://www.axis-shield.com) at room
temperature [31].
The concentration of isolated PBMCswas adjusted to 23 106
cells per milliliter in RPMI 1640 (EuroClone) including 10% FBS.
Twenty hours later, PBMCswere washed and used for the experi-
ments described below.
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Coculture Experiments
The hAFSCs were seeded for all experiments in multiwell plates
(6-well cultureplates)whenconfluencewas reached (approximately
300,000 cells per well) and were pre-exposed or not to PBMCs for
24 hours prior to coculture with fresh isolated PBMCs.
Cocultures in contact were obtained by adding 2 ml of PBMC
suspension (23106cells permilliliter) tohAFSCcultureplates. For
Transwell culture, PBMCswere seededonto polycarbonatemem-
brane cell culture inserts (Corning, Corning, NY, http://www.
corning.com). For conditioned medium (CM) experiments,
PBMCs were suspended in RPMI obtained from hAFSC culture
(i.e., CM) for up to 5 days. In some experiments, 1 mg/ml of
anti-HGF neutralizing antibody (Sigma-Aldrich, St. Louis, MO,
https://www.sigmaaldrich.com) was added to the coculture. In
general, cocultured cells and controlsweremaintained for 5 days.
Western Blotting
Whole-cell lysates fromhAFSCs andPBMCswereprocessedasde-
scribed previously [32]. Some sample were pretreated for 30
minutes with inhibitors of the Akt pathway [33]: a reversible in-
hibitor of PI3K LY294002 (25 mM, Calbiochem no. 440202; EMD
Millipore, Billerica, MA, http://www.emdmillipore.com), an
allosteric Akt inhibitor MK-2206 (0.1 mM, no. 51078; Selleck
Chemicals, Houston, TX, http://www.selleckchem.com), and
a dual ATP-competitive PI3K andmammalian target of rapamycin
inhibitor BEZ235 (0.1 mM, no. 10565; Cayman Chemical, Ann
Arbor, MI, https://www.caymanchem.com).
Primary antibodies were used against phospho-c-MET,
phospho-Akt, phospho-ERK (Cell Signaling Technology, Beverly,
MA, http://www.cellsignal.com); PARP, HGF, b-actin (Santa Cruz
Biotechnology); and cleaved caspase 3 and 9 (Sigma-Aldrich).
HGF Immunoassay
Concentration of HGF in the conditioned media of cultured
hAFSCs was measured by using a sandwich ELISA, according to
the manufacturer’s instructions (Boster Biological Technology,
Pleasanton, CA, http://www.bosterbio.com) [34]. Conditioned
media were centrifuged before testing. Samples were run in du-
plicate. A standard curve was constructed using known concen-
trations of recombinant human HGF (0–8,000 pg/ml).
Evaluation of Apoptosis in Lymphocytes by
Flow Cytometry
Apoptosis was quantitatively measured using propidium iodide.
The staining process was performed according to the manufac-
turer’s instructions. Data were obtained using flow cytometric
analysis with fluorescence-activated cell sorting within 1 hour.
Apoptosis Assay
PBMCs (106 cells) were removed from coculture and washed
with phosphate-buffered saline, and 50 ml of this suspension
(0.5 3 106cells) was allowed to adhere to the slide for 10
minutes at room temperature. After 3washes with 50ml of bind-
ingbuffer (10mMHEPES, pH7.5, containing 140mMNaCl and2.5
mMCaCl2), the specimenwas incubated for 15minuteswith 50ml
of double staining solution (binding buffer containing 0.25 ml of
annexin V-Cy3 and 0.25 ml of CFDA; Sigma-Aldrich). Finally, the
specimen was washed 5 times with 50 ml of binding buffer,
mounted with 15 ml of binding buffer, and visualized under fluo-
rescence microscopy.
Statistical Analysis
In vitro experiments were performed in triplicate. For quantita-
tive comparisons, values were reported as mean 6 SD based
on triplicate analysis for each sample. To test the significance
of observed differences among the study groups, analysis of var-
iancewith post hoc Bonferroni correction or Student’s t testwere
applied. A p value ,.05 was considered statistically significant.
RESULTS
The hAFSCs were isolated from a heterogeneous cell population
of second-trimester amniotic fluid. After the selection of c-Kit-
positive cells, the culture maintained markers typical not only
of the mesechymal profile. In Table 1 we present a summary of
the characterization of hAFSCs obtained in our laboratory. These
data were previously published in part [9, 35] and were obtained
with different techniques, such as Western blot and immunoflu-
orescence. As already reported by other authors, we confirmed
that hAFSCs exhibit positivity for stromal mesenchymal markers,
such as CD73, CD90, and CD105 [8, 18, 35, 36] and Stro-1 and
CD271 [9].
Moreover, hAFSCs selected for c-Kit andmaintained in culture
for several passages expressed proteins typical of more primitive
stem cells features, such as SSEA4, Oct4, TRA-1-81, FOXO1, Sox2
[35], and Nanog [18]. Consequently, the differentiation potential
observed for hAFSCs was consistent with the expression of some
pluripotency-associated markers. We previously reported suc-
cessful differentiation in osteoblasts [25, 26]; in adipocytes, myo-
cytes, and pancreatic cells [34]; and in glial and neuronal cells [9].
Regarding the immunoregulatory potential of second-
trimester hAFSCs, it has been noted that human leukocyte antigen
A (HLA-A), HLA-B, and HLA-C are expressed, unlike HLA-DR [1, 36].
Moreover, the production in the secretum of some immune-
modulating molecules has been proved for hAFSCs [1, 18, 36].
In order to shed a light on this issue, we used a microarray
designed to test thepresence in the secretumof several cytokines
and chemokines: IL-1a, IL-1b, IL-4, IL-6, IL-8, IL-10, IL-13, MCP-1,
IFN-g, and TNF-a. Table 2 shows only the highest values obtained
from the analysis of hAFSC culture in standard growth conditions
or pre-exposed to PBMCs (AFSC active). This analysis confirmed
the presence of IL-6 in hAFSC secretum [1], mostly in activated
hAFSC medium. In this last condition, we also observed a detect-
able value of IL-8. The presence of MCP-1 is still evident in unac-
tivated hAFSCs, but pre-exposure to PBMCs causes a large
increase (10 times).
Immune modulation can be exerted by other soluble factors,
IDO [18] andHGF [37]. HGF has been shown to exert regenerative
activity outside the liver, including stimulation of angiogenesis. In
line with other soluble factors associated with regenerative pro-
cesses, HGF possesses immune modulatory activity. Conse-
quently, we focused our attention on the role of HGF in the
immunosuppressive effects of hAFSCs.
HGF expression in hAFSCs was evaluated in different culture
conditions. Figure 1A shows the Western blot analysis of total
lysates of hAFSCs, even after 2 weeks of culture in osteogenic dif-
ferentiation medium or after 3 weeks in neurogenic medium. In
all of these conditions, HGF was detectable at comparable
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intensities, indicating that this property was maintained dur-
ing differentiation.
Results obtained by Western blot were confirmed by immu-
nofluorescence.UndifferentiatedhAFSCs strongly expressedHGF
within the cytoplasm in a spot-like distribution (Fig. 1B). HGF pro-
duction by hAFSCs seeded at confluencewasmeasured in culture
media obtained after 1–5 days in culture. The graph on the left of
Figure 1C shows time-dependent accumulation of HGFwithin the
medium. Comparingmedia of hAFSCs grown in normal conditions
versus preactivated for 24 hours with exposure to PBMCs, the
ELISA assay showed an increase (3 times) of HGF level that was
also observed with microarray for other soluble factors (Table 2).
We compared the effect of exogenous HGF and hAFSC CM on
the PBMC signaling pathway downstream of HGF binding to its re-
ceptor. As expected, HGF causedan increase in thephosphorylation
of its receptor c-MET,exposedonPBMCmembranes (Fig. 2A). In the
sameway,hAFSCCMexposure inducedactivationof theHGF recep-
tor. Akt and ERK1/2 phosphorylation were then analyzed. Com-
pared with PBMC control, samples incubated with pure HGF or
hAFSCCMfor24hours showedactivationof theAktpathway,unlike
ERK1/2. Consequently, we tested the efficacy of different Akt path-
way inhibitors, such as LY294002, MK-2206, and BEZ235.
Figure 2B shows (on the left) the effect of these inhibitors on
PBMCs at the concentration usually reported in literature and in
theMaterials andMethods section. ThephosphorylationofAkt de-
creased, and, in parallel, the cleaved PARP (marker of apoptosis)
increased, confirming the prosurvival role of Akt in PBMCs. In con-
trast, samples of PBMCs exposed to hAFSC CM showed a different
reaction to inhibitor incubation; in fact, although a reduction in
phosphorylation of Akt still occurred, an increase in cleaved PARP
levels was not evident. This observation could suggest that hAFSC
CMexposure induced activation of c-MET, leading to phosphoryla-
tion of Akt despite a negative effect on PBMC viability. The major
armofc-METsignaling is thePI3K/Akt signalingaxis.Whenc-MET is
phosphorylated, it binds and activates PI3K, which probably pro-
motes cell viability and motility [38], also linking c-MET signaling
to theMAPKcascade [39]. Functional effectsofHGFdependmostly
on cell context, and thus both apoptotic and antiapoptotic effects
of HGF have been observed [40].
In order to better investigate the effect of interaction be-
tween hAFSCs and PBMCs, coculture experiments were per-
formed for longer times. Samples of immune cells exposed to
different kinds of coculture: (a) in CM, culture medium was de-
rived after 5 days of hAFSCs in RPMI serum free; (b) in the
Transwell condition, hAFSCs were in coculture with PBMCs but
physically separated by a membrane; (c) in coculture of hAFSCs
and PBMCs, PBMCs and hAFSCs were physically in contact.
PBMCs were then collected and analyzed by fluorescence-
activated cell sorting (FACS), Western blot, and confocal
microscopy.
Figure 3A shows representative images of PBMCs alone or ex-
posed to CM, Transwell, and hAFSC-PBMC coculture with hAFSCs
analyzed by Western blot for apoptotic markers. The cleaved
formofPARPandcaspase3 significantly increased in thepresence
of hAFSC secretum in all the three coculture conditions.
Annexin V analysis was performed on PBMCs cultured alone
(control) and PBMCs coculturedwith normal hAFSC culture or ac-
tivated hAFSCs to confirm apoptotic cell death in immune cells.
Figure 3B shows representative images of PBMCs cultured alone
or exposed to hAFSCs or activated hAFSCs, labeled by annexin V.
The presence of cells stained with red rings increased in both ex-
posure conditions with respect to the PBMCs cultured alone, in-
dicating the onset of an apoptotic process,mostly in cells exposed
to activated hAFSC conditioned medium. In order to quantify ap-
optosis occurring in PBMCs, FACS analysis was performed after
staining with propidium iodide (Fig. 3C). The percentage of apo-
ptotic cells in the presence or absence of CM obtained from nor-
mal hAFSC culture or activated hAFSCs is shown; in both
conditions, the cells in the sub-G1 phase reach ∼10% and 20%,
respectively. These values are significantly different from the
control and between each other.
The conditionedmediumobtained after 5 dayswas chosen to
test the efficacy of anti-HGF neutralizing antibody in reducing the
apoptotic process. In fact, the conditioned medium is cell free;
therefore, it is possible to perform preincubation for 1 hour with
the antibody in a shaking condition. Apoptosis was quantitatively
assessed by cytofluorimetric analysis (Fig. 3D). The percentage of
apoptotic PBMCs obtained from CMof hAFSCs in the presence of
anti-HGF significantly decreased, although it did not reach the
percentage of leukocytes cultured alone. Furthermore, no signif-
icant differences in the sub-G1 levelwereobserved inPBMCswith
the addition of anti-HGFneutralizing antibody in comparisonwith
PBMCs cultured alone.
This effect has been confirmed by Western blot analysis. The
expression of PARP and active caspase 9 and 3 was assessed in
Table 2. Inflammation microarray of conditioned media
Culture IL-6 IL-8 MCP-1
AFSCs 16.66 0.6 13.06 0.4 147.76 16.0
AFSCs active 718.16 11.0a 544.96 38.0a 1,242.26 81.0a
The table shows only the highest values (pg/ml) obtained from the
analysis of conditioned media from 5 days of human AFSC cultures
previously activated (AFSC active) or not (AFSCs) for 24 hours with
peripheral blood mononuclear cells in the Transwell condition.
ap , .0001 compared with AFSC values.
Abbreviation: AFSCs, human amniotic fluid stem cells.
Table 1. Summary of the characterization of hAFSCs isolated in our
laboratory
Multipotent mesenchymal





Stro1 WB Data not shown
Pluripotency-associated
markers
Oct4 WB, IF [9, 35]
Nanog WB Data not shown
SSEA4 WB [35]
Sox2 IF [35]
TRA-1-81 WB Data not shown
c-Kit WB, IF [9]
FOXO1 IF [35]
Abbreviations: hAFSCs, human amniotic fluid stem cells; IF,
immunofluorescence; WB, Western blot.
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whole leukocyte lysates cultured alone and cocultured with
hAFSCs active in the Transwell condition (Fig. 3E). The increase
of these markers confirms the presence of apoptotic death.
DISCUSSION
MSCs can give rise to differentiated cells of the mesodermal
lineage including bone, fat, cartilage, tendon, and muscle
[41–43]. In addition, their ability to evade immunosurveillance
after cell transplantation and to suppress immune response
has made BM-MSCs a particularly attractive candidate for clinical
use [44, 45]. In particular, it was observed that BM-MSCs could
suppress lymphocyte proliferation and activation in response to
the allogenic activation or chemical stimulation in vitro or in vivo
[43, 46, 47].
Among stem cell sources, the amniotic fluid contains mul-
tiple cell types derived mainly from exfoliating surfaces of the
developing fetus [48]. These include cells from the fetal skin,
respiratory system, and urinary and gastrointestinal tracts,
along with populations of MSCs [49]. Immunoselection for c-Kit
(CD117), the cell surface receptor for stem cell factor, designated
AFSCs with no signs of malignant transformation, chromo-
somal abnormalities, or loss of differentiation potential [8].
In this study,we confirmed that hAFSCs cultured in our exper-
imental conditions were positive for the mesenchymal stem cell
markers CD73, CD90, CD105, CD271, and Stro-1 but also for
typical markers of embryonic stem cells, such as SSEA4, Oct4,
Nanog, FOXO1, Sox2, and TRA-1-81.
CD271, also known as low affinity nerve growth factor recep-
tor (LNGFR) or p75NTR, belongs to the low-affinity neurotrophin
receptor and tumor necrosis factor receptor superfamily [50].
This cell surfacemarker potentially defines anMSCprecursor sub-
population with immunosuppressive and lymphohematopoietic
engraftment-promoting properties [51]. The expression of this
marker in most amniotic fluid stem cell populations should sug-
gest immune-regulation potential.
Differentiation plasticity can be justified by the expression of
several pluripotent stem cell markers. SSEA4, an early embryonic
glycolipid antigen, is commonly used as a marker for undifferen-
tiated pluripotent human embryonic stem cells and cleavage to
blastocyst-stage embryos but also identifies the adult mesenchy-
mal stem cell population.
The transcription factor Oct4 has essential functions for
the maintenance of pluripotent embryonic and germ cells of
mammals [52]. Sox2, a member of the SoxB1 transcription
factor family, is an important transcriptional regulator in plu-
ripotent stem cells. Together with Oct4 and Nanog, they coop-
eratively control gene expression in pluripotent stem cells and
maintain their pluripotency. The FOXO transcription factors
have an essential role in maintaining stem cell identity [53].
Finally, all human pluripotent stem cells express TRA-1-81
antigen.
Figure 1. HGFexpression byhumanAFSCs (hAFSCs). (A):Western blot analysiswith anti-HGF revealed total lysates of undifferentiated hAFSCs,
after 2weeks in culturewith osteogenicmedium, and after 3weeks in culturewith neurogenicmedium. Actin detectionwas performed to show
the amount of protein loaded in each lane. Presented data are representative of three independent experiments, and the gray density values
were normalized to that of actin. (B): Representative immunofluorescence images obtained at different magnifications of undifferentiated
hAFSCs labeled with DAPI (blue) and HGF (green). Scale bar = 10mm. (C): ELISA quantification (normalized to protein content) of HGF in media
obtained from hAFSCs after 1–5 days in culture (left) and compared with hAFSCs preactivated for 24 hours and after 5 days in culture (right).
Student’s t test showed a significant difference between samples. ppp, p # .0001. Presented data are the average of three independent experi-
ments. Abbreviations: AFSC, amniotic fluid stem cells; DAPI, 49,6-diamidino-2-phenylindole; ELISA, enzyme-linked immunosorbent assay; HGF,
hepatocyte growth factor; Neuro, neurogenic; Osteo, osteogenic; TL, total lysate; Undiff, undifferentiated.
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AFSCs are able to suppress inflammatory responses in vitro,
and soluble factors are an essential for communication between
lymphocytes and AFSCs. Considering their extensive self-renewal
capacity, possibility for banking, and absence of tumorigenicity,
AFSCs can be evaluated as a superior source of stable, well-
characterized, “off the shelf” immunomodulatory cells for a vari-
ety of immunotherapies and have the ability to avoid allogenic
rejection [1].
It has been proven that AFSCsmodulate lymphocyte prolifer-
ation in a different manner according to gestational age. Second-
trimester AFSCs showed low expression of HLA class I molecules
and absence of HLA II, and their features were associated with
lower sensitivity to natural killer (NK) cell-mediated lysis.
Second-trimester AFSCs did not efficiently inhibit T and NK cell
proliferation but could suppress B-cell proliferation, which was
not affected by the first- and third-trimester AFSCs [36]. In con-
trast, the mechanism of hAFSC immunoregulation by soluble
factors has been elucidated only in part. Under growth condi-
tions, amniotic fluid stem cells and BM-MSCs release relatively
low levels of very few cytokines, but on activation by PBMCs,
high levels of cytokines are released [1]. In fact, the microarray
shown in Table 2 demonstrated the activating effect of pre-
exposure to PBMCs on the secretion of immunomodulatory
factors.
Based on these observations, we decided to evaluate the im-
munosuppressive actions of hAFSCs directed toward the whole
peripheral blood leukocyte population, focusing on the secreted
factor HGF. HGF is a potent immunomodulatory factor that in-
hibits dendritic cell function along with differentiation of IL-
10-producing regulatory T cells, decrease in IL-17-producing
T cells, and downregulation of surfacemarkers of T-cell activation
[23]. Apoptotic effects of HGF and c-Met are not yet fully under-
stood [39] but have been observed in several cell lines such as
ovarian carcinoma cells, breast carcinoma cells, mouse sarcoma
cells, and mouse hepatocarcinoma cells [54–57]. Yang et al. [58]
found that hepatic stellate cells send an apoptotic message to
T cells and, at the same time, inhibit antigen-specific T-cell activity.
Bottai et al. [37] demonstrated the secretion of HGF by hAFSCs
isolated from third trimester amniotic fluid and focused on its en-
docrine role in targeting the injury site in an animalmodel without
evaluating its possible immunoregulating capacity.
Initially we demonstrated that HGF is released by hAFSCs
in the medium and after different types and durations of
differentiation protocols, suggesting that the potential immu-
nomodulatory property could be maintained in vivo during dif-
ferentiation and after engraftment. HGF production is time
dependent and enhanced by hAFSC preactivation with PBMCs,
a condition reflecting the realistic situation occurring after the in
vivo implant.
We next examined the effect of short time exposure to hAFSC
secretum on PBMCs compared with pure HGF. Figure 2 shows
that 24 hours with hAFSC CM activate the typical HGF pathway
of c-MET/Akt in PBMCs and induce exogenousHGF; however, this
phenomenon is not linked to the obvious survival stimulus, as
demonstrated by the unexpected effect of Akt inhibitors.
PBMC apoptotic portion was increased by the presence of
hAFSCs in all coculture conditions via a caspase-dependent pro-
cess. The apoptotic effect was augmented by increased HGF pro-
duction after hAFSC activation. By neutralizing the HGF activity,
the immunosuppressive action of the hAFSCs was partially abol-
ished. These results suggest that hAFSCs possess immunomodu-
latory properties involving HGF production.
CONCLUSION
Our findings have provided new information about the immune
modulatorypropertiesofhAFSCs. It is clear that immunomodulation
Figure 2. Human AFSC (hAFSC) CMmodulation of immune cell signaling pathways. (A):Western blot analysis of lysates of PBMCs exposed to
1ng/mlHGForhASCFCMfor 24hours revealedphospho-c-MET, phospho-Akt, andphospho-ERK. (B):Westernblot analysis of cleavedPARPand
phospho-Akt in samples of PBMCs exposed or not to hAFSC CM for 24 hours and pretreated for 30 minutes with LY294002, MK-2206, and
BEZ235. Actin detection was performed to show the amount of protein loaded in each lane. Presented data are representative of three inde-
pendent experiments, and quantification analysis is shown in the graphs. ppp, p, .0001, pp, p, .01 comparedwith the control or AFSC values.
Abbreviations: AFSC, amniotic fluid stem cells; cl, cleaved; BEZ, BEZ235; CM, conditionedmedium; Ctrl, control; HGF, hepatocyte growth factor;
LY, LY294002; MK, MK-2206; PBMC, peripheral blood mononuclear cells; Ph, phospho.
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is not a peculiar feature of MSC-like cells but actually general prop-
erty of stemcells thatmaybe inducedor enhancedby inflammatory
stimuli. Understanding these mechanisms may help identify novel
therapeutic strategies and recognize the most effective stem cell
class for interfering with damage-mediated inflammation and in-
ducing tissue regeneration and organ repair [16]. Consequently,
further in vivo studies will clarify whether these considerations
for MSCs may be applied to c-Kit-positive stem cell populations
such as AFSCs.
We conclude that AFSCs can be considered as a new thera-
peutic tool for many pathologies, taking into account the differ-
entiation potential in vitro toward cell lineages belonging to the
three germ layers and the different ways to regulate immune
responses.
Figure 3. Apoptosis of immune cells exposed to human AFSC (hAFSC) coculture. (A):Western blot analysis of lysates of peripheral blood mono-
nuclear cells (PBMCs) exposed for 3 days to hAFSCs by conditioned medium, Transwell condition, or direct contact. Then immunoblot directed to
cleaved PARP and caspase 3was performed. Presented data are representative of three independent experiments, and the gray density values are
shown in the graph. pppp, p, .0001; pp, p, .01. (B): Representative immunofluorescence images of annexin V (red) and CFDA (green) labeling of
PBMCsexposed for3days tomedia (CM)obtained from5daysofhAFSCspreactivated (AFSCactive)ornot (AFSC). (C):Representative fluorescence-
activated cell sorting (FACS)analysisofpropidium iodide (PI) fluorescenceof lymphocytesexposed for3days tomedia (CM)obtained from5daysof
hAFSCspreactivated (AFSCactive)ornot (AFSC) for24hours.p,p, .05;pp,p, .01vs. control; °°,p, .01vs.AFSC. (D):RepresentativeFACSanalysis
of PI fluorescence of lymphocytes cultured alone, after exposure to CM of activated hAFSCs, and in presence of anti-HGF neutralizing antibodies.
Histograms represent themeans of three different experiments6 SD. pp, p, .01 vs control; °°, p, .01 vs. AFSC CM. (E):Western blot analysis of
lysates of PBMCs exposed to CMof activated hAFSCs and in the presence of anti-HGF neutralizing antibodies revealed cleaved PARP and caspase 3
and 9. Actin detectionwas performed to show the amount of protein loaded in each line. Presented data are representative of three independent
experiments, and the gray density values are shown in the graph. ppp, p, .0001 vs. control; °°°,p, .0001; °°, p, .01 vs. CM. Abbreviations: AFSC,
amniotic fluid stem cells; a-HGF, anit-hepatocyte growth factor; Casp3, caspase 3; cl, cleaved; CM, conditioned medium; CO, direct contact; Ctrl,
control; TW, Transwell.
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